Drug intelligence / Profile preview

Hexuemingmu Tablet

Development stage
Unknown
Lead developer
Grand Pharmaceutical
Administration
Oral
01

Overview

Hexuemingmu Tablet is a Chinese patent medicine (CPM) or traditional Chinese medicine (TCM) composed of 19-flavored herbs, including Chuanxiong, Angelica, Red Pae, Radix, Moganlian, Nvzhenzi, Puhuang, Danpi, Danshen, and Chongweizi. It is primarily used in ophthalmology for the treatment of various retinal degenerative and fundus hemorrhagic diseases. Its traditional therapeutic properties include cooling the blood, removing blood stasis, stopping bleeding, nourishing yin, nourishing the liver, and improving eyesight. Modern pharmacological research indicates that Hexuemingmu Tablet exhibits anticoagulant, antivascular endothelial, hemorheological improvement, anti-inflammatory, anti-swelling, and antioxidant activities, contributing to its efficacy in improving ocular circulation and promoting the absorption of hemorrhage and exudation in the fundus.

Other names
Hexue Mingmu tabletHXMMTHe xue ming mu tablet
02

Targets

VEGFA (Vascular endothelial growth factor A)GSH (Glutathione)IL-6 (Interleukin 6)LDH (L-lactate dehydrogenase A chain)NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on Hexuemingmu Tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hexuemingmu Tablet.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call